These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22295988)

  • 21. Neuraxial pain relief for intractable cancer pain.
    Sloan PA
    Curr Pain Headache Rep; 2007 Aug; 11(4):283-9. PubMed ID: 17686392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential uses of topical opioids in palliative care--report of 6 cases.
    Krajnik M; Zylicz Z; Finlay I; Luczak J; van Sorge AA
    Pain; 1999 Mar; 80(1-2):121-5. PubMed ID: 10204724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of continuous intravenous infusion of morphine in the cancer pain relieving therapy].
    Kato Y; Kato A
    Nihon Rinsho; 2001 Sep; 59(9):1789-93. PubMed ID: 11554053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can levorphanol be used like methadone for intractable refractory pain?
    McNulty JP
    J Palliat Med; 2007 Apr; 10(2):293-6. PubMed ID: 17472497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxycodone for cancer-related pain.
    Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer.
    Glare P; Walsh D; Groh E; Nelson KA
    Am J Hosp Palliat Care; 2002; 19(5):343-50. PubMed ID: 12269781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous intrathecal meperidine for severe refractory cancer pain: a case report.
    Souter KJ; Davies JM; Loeser JD; Fitzgibbon DR
    Clin J Pain; 2005; 21(2):193-6. PubMed ID: 15722815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
    Zheng S; He L; Yang X; Li X; Yang Z
    Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strong opioids and constipation].
    Schwarzer A; Nauck F; Klaschik E
    Schmerz; 2005 Jun; 19(3):214-9. PubMed ID: 15004747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of severe cancer pain via spinal catheters].
    Andersen JS; Markers PI; Valentin N
    Ugeskr Laeger; 1996 Nov; 158(46):6613-6. PubMed ID: 8966828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series.
    Khoo SY; Aziz FA; Nambbiar P
    J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-controlled analgesia (PCA) in the domiciliary care of tumour patients.
    Meuret G; Jocham H
    Cancer Treat Rev; 1996 Jan; 22 Suppl A():137-40. PubMed ID: 8625340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain.
    Nitescu P; Dahm P; Appelgren L; Curelaru I
    Clin J Pain; 1998 Mar; 14(1):17-28. PubMed ID: 9535310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.
    Rauck RL; Cherry D; Boyer MF; Kosek P; Dunn J; Alo K
    J Pain; 2003 Oct; 4(8):441-7. PubMed ID: 14622664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
    Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
    Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioids for cancer pain - an overview of Cochrane reviews.
    Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
    Currow DC; Quinn S; Ekstrom M; Kaasa S; Johnson MJ; Somogyi AA; Klepstad P
    BMJ Open; 2015 May; 5(5):e006818. PubMed ID: 25948405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioids for cancer pain: the challenge of optimizing treatment.
    Plante GE; VanItallie TB
    Metabolism; 2010 Oct; 59 Suppl 1():S47-52. PubMed ID: 20837194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous flurbiprofen axetil enhances analgesic effect of opioids in patients with refractory cancer pain by increasing plasma β-endorphin.
    Wu TT; Wang ZG; Ou WL; Wang J; Yao GQ; Yang B; Rao ZG; Gao JF; Zhang BC
    Asian Pac J Cancer Prev; 2014; 15(24):10855-60. PubMed ID: 25605189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.